Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-29 · accession 0001437749-21-029532 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-30 | 2021-12-29 | BLFS | Rice Michael | CEO, Dir | S - Sale | $39.37 | -928 | 259.5K | -0.4% | -$36.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | S | D | 928 | $39.37 | 259,455 | D | — | — |